ARCHIVES

Phase III Study Evaluating Halaven Fails To Meet Primary Endpoints

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

NCAB Delays Approval Of New Comprehensive Center Guidelines

October 12, 1979

The Number of Adult Cooperative Groups Drops to Four As NSABP, RTOG And GOG Agree to Merge

October 21, 2011

Health Care Delivery: Value Of Informatics To PPMs Is a Message for Academic Centers

November 22, 1996

ODAC Reviews Post-Marketing Studies for Eight Indications

March 21, 2003

Vanderbilt physician-scientist Philip Browning, 51, dead of colon cancer.

June 25, 2004

Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer

August 27, 2010